Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
Máxima-topman Eggermont: ‘We beseffen niet hoe ver we vóórlopen’
jul 2020